<html>

        <head>
        <link href="../style1.css" rel="stylesheet" type="text/css">
        </head>
        <table border = 1>
        <tr>
        <th>PubMedID</th>
        <th>Sentence</th>
        <th>First Gene</th>
        <th>Second Gene</th>
        <th>Interaction</th>
        </tr>
        <body>
<tr class = "cellcolor">
<td>24284056</td>
<td>Detailed correlative analyses of individual patient samples revealed a significantly greater proportion of SCC in TMA Set 1 with higher PI3Kβ and lower PTEN expression when compared with AC</td>
<td>SCC</td>
<td>PTEN</td>
<td>Negative</td>
</tr>
<tr class = "cellcolor">
<td>24284056</td>
<td>CONCLUSIONS: We identify for the first time a subset of NSCLC more prevalent in SCC, with elevated expression of PI3Kβ accompanied by a reduction/loss of PTEN, for whom selective PI3Kβ inhibitors may be predicted to achieve greater clinical  benefit.</td>
<td>SCC</td>
<td>PTEN</td>
<td>Neutral</td>
</tr>
